| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.NEUROPHARM.2012.11.015 |
| P698 | PubMed publication ID | 23246909 |
| P2093 | author name string | Mark J Millan | |
| P2860 | cites work | Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autism | Q24620573 |
| A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells | Q29619964 | ||
| Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains | Q33569805 | ||
| A method for genetically installing site-specific acetylation in recombinant histones defines the effects of H3 K56 acetylation | Q40097842 | ||
| P921 | main subject | pathogenesis | Q372016 |
| neurodevelopmental disorder | Q3450985 | ||
| P304 | page(s) | 2-82 | |
| P577 | publication date | 2012-12-11 | |
| P1433 | published in | Neuropharmacology | Q15332439 |
| P1476 | title | An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapy | |
| P478 | volume | 68 |
| Q38161847 | A blueprint for research on Shankopathies: a view from research on autism spectrum disorder |
| Q36719177 | ADHD-associated dopamine transporter, latrophilin and neurofibromin share a dopamine-related locomotor signature in Drosophila |
| Q67496287 | Adolescent social isolation affects parvalbumin expression in the medial prefrontal cortex in the MAM-E17 model of schizophrenia. |
| Q38759421 | Altering the course of schizophrenia: progress and perspectives |
| Q41845204 | Association between pre- and perinatal exposures and Tourette syndrome or chronic tic disorder in the ALSPAC cohort |
| Q90623316 | BRD4 inhibition exerts anti-viral activity through DNA damage-dependent innate immune responses |
| Q38343860 | Bioethical conflicts of gene therapy: a brief critical review |
| Q36287896 | Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank |
| Q48318063 | Chromosomal Imbalances in Patients with Congenital Cardiac Defects: A Meta-analysis Reveals Novel Potential Critical Regions Involved in Heart Development |
| Q60933930 | Clustering, Pathway Enrichment, and Protein-Protein Interaction Analysis of Gene Expression in Neurodevelopmental Disorders |
| Q35956389 | Comorbidities in Neurology: Is adenosine the common link? |
| Q28833595 | DNA methylation: a mechanism linking environmental chemical exposures to risk of autism spectrum disorders? |
| Q50614505 | Developmental risks associated with use of psychoactive drugs during pregnancy are largely unknown. |
| Q51739855 | Dysbindin-1 modifies signaling and cellular localization of recombinant, human D₃ and D₂ receptors. |
| Q33620153 | Dysfunction and Dysconnection in Cortical-Striatal Networks during Sustained Attention: Genetic Risk for Schizophrenia or Bipolar Disorder and its Impact on Brain Network Function |
| Q43285656 | Early rearing history influences oxytocin receptor epigenetic regulation in rhesus macaques. |
| Q60048499 | Epigenetic Alterations in Prenatal Stress Mice as an Endophenotype Model for Schizophrenia: Role of Metabotropic Glutamate 2/3 Receptors |
| Q92290376 | Epigenetic Effects of Polybrominated Diphenyl Ethers on Human Health |
| Q61818127 | Epigenetic Factors in Late-Onset Alzheimer's Disease: and Gene Polymorphisms, Metabolic Transsulfuration and Methylation Pathways, and B Vitamins |
| Q38946328 | Epigenetic Mechanisms in Psychiatric Diseases and Epigenetic Therapy |
| Q28072370 | Epigenetic Therapeutics: A New Weapon in the War Against Cancer |
| Q38742951 | Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases |
| Q38743021 | Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia. |
| Q37706667 | Epigenetic analysis of neurocognitive development at 1 year of age in a community-based pregnancy cohort |
| Q37192260 | Epigenetic basis for the development of depression in children |
| Q37237028 | Epigenetic findings in autism: new perspectives for therapy |
| Q39267995 | Epigenetic programing of depression during gestation |
| Q34498966 | Epigenetic regulation of pluripotency and differentiation |
| Q38584495 | Epigenetics and Child Psychiatry: Ethical and Legal Issues |
| Q28388390 | Epigenetics, stress, and their potential impact on brain network function: a focus on the schizophrenia diatheses |
| Q48339206 | Evaluation of Motor Skills in Children with Rubinstein-Taybi Syndrome |
| Q34150427 | Food-derived opioid peptides inhibit cysteine uptake with redox and epigenetic consequences |
| Q39406947 | Histone Lysine Methylation and Neurodevelopmental Disorders |
| Q36059026 | Human Pluripotent Stem Cell-derived Cortical Neurons for High Throughput Medication Screening in Autism: A Proof of Concept Study in SHANK3 Haploinsufficiency Syndrome |
| Q24614496 | Hydroquinone increases 5-hydroxymethylcytosine formation through ten eleven translocation 1 (TET1) 5-methylcytosine dioxygenase |
| Q37058606 | Increased abundance of translation machinery in stem cell-derived neural progenitor cells from four schizophrenia patients. |
| Q36983395 | Increased cortical expression of the zinc transporter SLC39A12 suggests a breakdown in zinc cellular homeostasis as part of the pathophysiology of schizophrenia |
| Q35030790 | Introduction to the special research topic on the neurobiology of emotion-cognition interactions |
| Q31147573 | MK-801, a NMDA receptor antagonist, increases phosphorylation of histone H3 in the rat medial prefrontal cortex |
| Q34560692 | MTHFR Gene C677T Polymorphism in Autism Spectrum Disorders |
| Q40705432 | Mental disorders in childhood and young adulthood among children born to women with fertility problems |
| Q31020010 | Merging data from genetic and epigenetic approaches to better understand autistic spectrum disorder |
| Q39248707 | MicroRNAs as biomarkers for psychiatric disorders with a focus on autism spectrum disorder: Current progress in genetic association studies, expression profiling, and translational research |
| Q38178068 | Neurobiology of autism gene products: towards pathogenesis and drug targets. |
| Q92591097 | Neuroimaging Biomarkers for Alzheimer's Disease |
| Q41573540 | New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis |
| Q38195644 | New criteria for supplementation of selected micronutrients in the era of nutrigenetics and nutrigenomics |
| Q38926246 | New drug developments in psychosis: Challenges, opportunities and strategies |
| Q46893695 | No increase in autism-associated genetic events in children conceived by assisted reproduction |
| Q52320951 | Non-Coding RNA as Novel Players in the Pathophysiology of Schizophrenia. |
| Q47283974 | Novel schizophrenia risk factor pathways regulate FEZ1 to advance oligodendroglia development. |
| Q38110358 | On 'polypharmacy' and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisal |
| Q34557464 | Parent ratings of ability to consent for clinical trials in fragile X syndrome |
| Q34647027 | Perinatal oxytocin increases the risk of offspring bipolar disorder and childhood cognitive impairment |
| Q38839950 | Pharmacotherapy of conduct disorder: Challenges, options and future directions. |
| Q47950653 | Phenotype comparison confirms ZMYND11 as a critical gene for 10p15.3 microdeletion syndrome. |
| Q37445268 | Placental HTR2A methylation is associated with infant neurobehavioral outcomes |
| Q43450643 | Problems and solutions to filling the drying drug pipeline for psychiatric disorders: a report from the inaugural 2012 CINP Think Tank |
| Q57647180 | Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing |
| Q27500448 | Schizophrenia: One Coat of Many Colors |
| Q42341535 | Special Issue Introduction: Role of Epigenetic Gene Regulation in Brain Function |
| Q44244898 | Spectrum of neurodevelopmental disabilities: a cohort study in hungary |
| Q26853512 | Subjective experience of episodic memory and metacognition: a neurodevelopmental approach |
| Q92765086 | Targeted Downregulation of kdm4a Ameliorates Tau-engendered Defects in Drosophila melanogaster |
| Q52314919 | The Communication Between the Immune and Nervous Systems: The Role of IL-1β in Synaptopathies. |
| Q27314764 | The Regulation of Cytokine Networks in Hippocampal CA1 Differentiates Extinction from Those Required for the Maintenance of Contextual Fear Memory after Recall |
| Q34426210 | The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity? |
| Q47382890 | The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders |
| Q28081897 | The neurobiology of emotion-cognition interactions: fundamental questions and strategies for future research |
| Q37600917 | The roles of DNA methylation of NR3C1 and 11β-HSD2 and exposure to maternal mood disorder in utero on newborn neurobehavior |
| Q47547157 | What causes psychosis? An umbrella review of risk and protective factors |
| Q52585640 | [Genetics and epigenetics of schizophrenia and other psychoses]. |
Search more.